1.Three routes for interventional chemotherapy in the treatment of NSCLC later lung cancer
Congjing GAO ; Nanzheng ZHANG ; Yue SHI
Journal of Interventional Radiology 1994;0(04):-
Objective To analyze the treating of 443 NSCLC cases in the middle and late stages. Three ways of drug administration had been reported as follows: intravenous drop (IVD) 301 cases, bronchial artery infusion (BAI) 64 cases, bronchial and pulmonary arteres for dual infusin (DAI) 78 cases. Methods From 1980 on 97th Hospital of PLA had already treated 443 cases of NSCLE of advance lung cancer. Three ways of drug administration had been analyzed. Results The recent effective rates attained as 53.0%, 73.4% and 98.7% with mean survival rates of 7.3、10.8 and 12.4 months respectively for the 3 groups. Conclusion The authors consider that the combination of MFP or EAP and CAMB is a better plan to treat NSCLC. The high concentration of chemical drugs directly act on the local tumor by applying BAI with high shrinking rate of tumor and increased resection rate. Because of double blood supply of lung by bronchial and pulmonary arteries, DAI will correct certain defects of BAI to increase therapeutic effect as well as reduce and avoid certain side effects of BAI.
2.Observation on Azygos System in 78 Chinese Adults
Congjing GAO ; Eryu CHEN ; Suzhen ZHANG
Journal of Third Military Medical University 1984;0(02):-
The azygos system was studied on 78 Chinese adult cadavers. The occurrence of the type of coexisted azygos, hemiazygos and accessory hemiazygos veins is 64.10%. The components of hemiazygos and accessory hemiazygos veins are sub- ject to such a large variation that the division of the azygos system into three major trunks is not always practicable since no generally-agreed criterion can be observed. The authors, according to Seib's suggestion! classify the azygos system into three types, that is, the double trunk, the intermediate, and the single trunk types, based on the condition of the interruptions of the hemiazygos. system Intermediate type occurs most frequently and its occurrence is 52.56% in this series.The interruptions of the hemiazygos system and the communications between azygos vein and hemiazygos system are far more numerous in Chinese than in Caucasians. The racial difference of the azygos system between Chinese and Caucasian subjects suggests that the azygos system of the Caucasians more likely belongs to the embryonic type. The middle segment of the azygos vein runs to the left of the midline in adults, and the origin of the azygos system usually connects with the inferior vena cava or the renal vein.The findings mentioned above might arouse the interest or the attention of the clinicians.
3.Cytokine-induced killer cell for interventional chemotherapy of hepatocellular carcinoma
Yue SHI ; Congjing GAO ; Shengliang DONG ; Fuxing CHEN ; Yongmao XU
Journal of Interventional Radiology 1994;0(04):-
Objective To evaluate the clinical effect of hepatocellular carcinoma treatment with a combination therapy of transcather arterial super liquefied lipiodol embolization and cytokine-induced killer cell(CIK) infusion.Methods There were 3 groups in this study,group 1:38 cases of HCC patients treated with a combination therapy of transcather arterial super liquified lipiodol embolization and CIK infusion;group 2:80 cases of HCC patients treated with a combination therapy of transcather arterial super liquefied lipiodol embolization and percutaneous intratumoral ethanol injection;group 3:134 cases of HCC patient treated with transcather arterial super liquefied embolization.Finally,the outcomes of the 3 groups were compared.Results The short term effective rates of group 1,2 and 3 were 76.1%,41.3% and 14.9% respectively,simultaneously with significant difference of changes concerning AFP value among the three groups especially in group 1 the AFP decrease to normal level while those of the other two groups still remain in higher levels.Conclusions The living quality and survival rate of HCC patients could be improved by a combination therapy of transcather arterial super liquefied lipiodal embolization and CIK infusion.(J Intervent Radiol,2007,16:235-239)